Based on the trove of scientific studies on buccy its effectiveness is the least of my worries.
What concerns me most is whether the data is overwhelming enough to ensure the fda has no choice but to approve the ep changes which then paves the way for the eua filing.
Looking forward to the dsmb meeting convened to analyze the remaining patient results, and their subsequent decision.
News 
Market Data 
Discover 
AI
